Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for December 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Machine Learning …
Read More »APO(a)-LRX Found to Reduce Lipoprotein(a) Levels
Dose-dependent reduction found in patients with elevated lipoprotein(a) levels, cardiovascular disease
Read More »Diabetes Mellitus May Increase Risk for Developing Heart Failure
Increased risk for heart failure also seen in group of participants without diastolic dysfunction
Read More »Gastric Sleeve Tied to Lower Risk for Subsequent Procedures
But rates of bariatric conversion, revision procedures higher for gastric sleeve versus gastric bypass
Read More »Poor Diet Contributes Substantially to Cardiometabolic Disease Costs
Diet tied to more than $50 billion in annual health care costs for heart disease, stroke, diabetes
Read More »High Lipoprotein(a) Is Risk Factor for CVD in Type 1 Diabetes
Lp(a) significant risk factor for macrovascular disease, albuminuria, calcified aortic valve disease
Read More »Inflammation Linked to Thyroid Dysfunction in Psoriasis Patients
Patients with thyroid dysfunction and psoriasis have higher serum C-reactive protein levels
Read More »Bariatric Surgery in Teens May Cut Diabetic Kidney Disease Risk
Decreased rates of hyperfiltration, elevated UAE seen among surgically treated obese teens with T2DM
Read More »Diabetes Prevalence Varies by Race, Ethnicity
Adjusted rates lower for non-Hispanic white versus Hispanic, non-Hispanic black, non-Hispanic Asian groups
Read More »Palliative Care Services Lagging Worldwide
More than half of world's population has poor, nonexistent access to palliative care
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.